Is it boom or bust on professional services?
Pharmacists could be disappointed by lack of professional services funding boost in 7CPA, barometer team claims Community pharmacists, who overwhelmingly endorsed increased remuneration and support for professional services as being …
1995: moving to boost professionalism
September 1995: a new pharmacy organisation has just been launched, an inquiry into the pharmaceutical industry is ongoing, and employed pharmacists are looking for more work A “long-awaited” industry initiative …
Keeping on top of things
Record bulk billing rates and massive telehealth take-up a sign of a successful COVID strategy: Minister says Federal Health Minister Greg Hunt has highlighted new data showing record GP bulk …
Price versus service: the patient impact
Patients who attend a discount pharmacy are more likely to have a poorer perception of its service standards and are less likely to adhere to their medicines, new research suggests …
Unintentional overdose numbers climb
The number of Australians who die from unintentional drug overdose each year continues to rise, and is set to worsen due to COVID-19, a new report reveals. Released on International …
Not so hazardous
We’ve already done enough for pharmacy: government responds to call for pharmacy hazard allowance by asserting its previous support for the profession The Federal Government has not offered any additional …
In short supply
TGA warns of a serious shortage of HRT patches, and their planned replacements, as well as some oral contraceptives Australia is facing a shortage of estradiol patches which will last …
1945: Peace and the PBS
Pharmacy leaders welcomed the end of World War II in our August 1945 issue, but a war of words was building over the government’s Pharmaceutical Benefits bill Pharmacy leaders expressed …
Cutting back at Blackmores
Complementary giant set to cut Australian jobs as its focus shifts to Asian markets and new digital opportunities Complementary medicine giant Blackmores is to cut about 10 per cent of …
Mixed decisions from scheduling committee
Ranitidine set to remain an S3 medicine, while TGA decides to downschedule migraine and acne treatments The Therapeutic Goods Administration (TGA) scheduling delegate has confirmed that the reflux treatment ranitidine …
Melatonin move supported
Call for comment on October deadline for Melatonin Pharmacist Only downscheduling, as doctors back S3 decision The Therapeutic Goods Administration has issued a call for further public submissions on its …
Keeping supply going in Stage 4
Pharmaceutical wholesalers exempt from Victorian warehouse and distribution restrictions: TGA The TGA’s Medicine Shortages Working Party – comprising pharmaceutical industry, wholesaler and health professional groups – says it supports and …